After more than 13 billion COVID vaccines given around the world, the largest studies to date point to the general safety of ...

71.3%. The third scenario, in which the booster dose was with the Pfizer vaccine, showed the highest percentages of effectiveness: 56.8% against symptomatic infections and 85.5% against severe cases.

The first signs that H5N1 avian flu was starting to spread from person to person would trigger a race to produce massive ...

The research promises to help scientists design and improve 'pan-coronavirus' vaccines that elicit broad, cross-protective ... Apr. 3, 2024 ... Than Delta, and Pfizer-BioNTech COVID Vaccine ...

Pfizer-BioNTech’s and Moderna’s mRNA-based COVID ... under an FDA priority review. Krazati just recently joined BMS’ arsenal after the company bought its maker, Mirati Therapuetics, for up ...

The Delaware State Police continues to investigate the fatal pedestrian hit-and-run crash that occurred on Harbeson Road last ...

“But 5-year ... carrying coronavirus to school environments.” Officials say a silver lining in the virus’ resurgence is more Texans are getting vaccinated, though the Food and Drug Administration has ...

After some healthy discussion, a bill creating a one-stop guide for both tenants and landlords is on its way to the House ...

A medical staff member prepares a vial of the Pfizer/BioNTech Comirnaty vaccine against Covid-19 at ... immune systems will be able to get a shot free of charge to reduce the impact ...

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday.

The English part of a global dispute billion dollar legal case involving big pharma giants Modern, Pfizer and BioNTech over ...

Pfizer will also have to address the issue “of adverse effects of the vaccines against the so-called Covid-19. In general, and also in detail in relation to the child population,” according to ...